Suchergebnisse - "Breccia, Massimo"

PubPharm (114)

1

Validation of imatinib therapy failure score (IMTF) in chronic phase chronic myeloid leukemia in real life practice

enthalten in: Leukemia & lymphoma | 2023

von Ielo, C. | Scalzulli, E. | Carmosino, I. | +4

2

One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission

enthalten in: European journal of haematology | 2023

von Laganà, A. | Pepe, S. | Scalzulli, E. | +8

3

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia : A study from the Registro Italiano LMC and Campus CML

enthalten in: Cancer | 2023

von Tiribelli, M. | Latagliata, R. | Breccia, M. | +38

4

Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

enthalten in: Annals of hematology | 2023

von Luciano, L. | Latagliata, R. | Gugliotta, G. | +18

5

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines : Findings from a Real-World Analysis in Italy

enthalten in: Advances in therapy | 2023

von Breccia, M. | Chiodi, F. | Nardozza, A. | +8

6

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase

enthalten in: Journal of hematology & oncology | 2022

von García-Gutiérrez, V. | Breccia, M. | Jabbour, E. | +2

7

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials : a real-life cohort observational study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Stagno, F. | Breccia, M. | Annunziata, M. | +24

8

Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure : a single center experience

enthalten in: Leukemia & lymphoma | 2021

von Pepe, S. | Scalzulli, E. | Colafigli, G. | +7

9

Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study

enthalten in: Leukemia | 2021

von Breccia, M. | Pregno, P. | Castagnetti, F. | +13

10

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

enthalten in: Annals of hematology | 2021

von Scalzulli, E. | Caocci, G. | Efficace, F. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]